2366
C. Gege et al. / Carbohydrate Research 343 (2008) 2361–2368
monomers were assigned in alphabetical order, beginning from the
aglycon, based in part on HMQC measurements. Target molecule 2
was measured at 303 K in a 320 mM solution of sodiumdodecyl
sulfate-d25 (SDS) in 0.5 mL D2O with 3-(trimethylsilyl)propionic
acid sodium salt-d4 as internal standard.33 MALDI-mass spectra
were recorded on a Kratos Kompact MALDI I instrument using a
2,5-dihydroxybenzoic acid matrix.
CHCl3); Rf = 0.52 (2:3 toluene–acetone); 1H NMR (600 MHz, CDCl3):
d 0.88 (t, 3H; CH3), 1.18 (d, J5,6 = 6.5 Hz, 3H; 6d-CH3), 1.18–1.32 (m,
22H; 11CH2), 1.68 (dd, J3,4 = Jgem = 12.4 Hz 1H; 3f-Ha), 1.85–2.20
(m, 56H; 18COCH3, CH@CHCH2), 2.58 (dd, J3,4 = 4.3, Jgem = 12.5 Hz,
1H; 3f-He), 3.22 (br s, 1H; 2c-H), 3.29–5.88 [m, 50H; HMQC: 3.30
(10-H), 3.37 (10-H), 3.46 (5c-H), 3.55 (5b-H), 3.63 (6f-H), 3.64 (4a-
H), 3.64 (5a-H), 3.68 (3b-H), 3.81 (20-H), 3.84 (5e-H), 3.86
(COOCH3), 3.86 (4c-H), 3.93 (6b-H), 4.03 (60b-H), 4.03 (6c-H),
4.04 (5f-H), 4.06 (6a-H), 4.09 (9f-H), 4.11 (60a-H), 4.21 (3c-H),
4.22 (6e-H), 4.26 (90f-H), 4.38 (60e-H), 4.40 (1b-H), 4.52 (3e-H),
4.53 (2a-H), 4.77 (1e-H), 4.79 (60c-H), 4.88 (2e-H), 4.88 (4f-H),
4.90 (1c-H), 4.95 (2d-H), 4.96 (4e-H), 5.00 (5d-H), 5.03 (Nf-H),
5.08 (2b-H), 5.20 (3d-H), 5.31 (4d-H), 5.32 (Nc-H), 5.33 (4b-H),
5.34 (1d-H), 5.44 (7f-H), 5.45 (40-H), 5.51 (8f-H), 5.53 (30-H), 5.59
(3a-H), 5.84 (1a-H), 5.85 (50-H)], 7.33–7.99 (m, 10H; 2C6H5); 13C
NMR (151 MHz, CDCl3, excerpt): d 15.83 (6d-C), 37.41 (3f-C),
49.12 (5f-C), 53.17 (OCH3), 58.3 (2c-C), 61.00 (6c-C), 61.37 (6e-C),
61.37 (6b-C), 61.71 (9f-C), 63.07 (6a-C), 63.32 (10-C), 63.65 (20-C),
64.09 (5d-C), 66.59 (7f-C), 67.31 (5a-C), 67.36 (4e-C), 67.58 (8f-
C), 68.01 (3d-C), 68.86 (2d-C), 69.04 (4b-C), 69.42 (4f-C), 69.82
(2e-C), 69.88 (3a-C), 70.77 (2b-C), 70.94 (5e-C), 71.17 (5b-C),
71.40 (3e-C), 71.56 (4d-C), 71.94 (6f-C), 72.37 (2a-C), 72.37 (3c-
C), 73.10 (5c-C), 74.28 (4c-C), 74.48 (30-C), 75.97 (3b-C), 76.61
(2d-C), 75.52 (4a-C), 75.96 (3b-C), 76.61 (4a-C), 95.28 (1d-C),
96.84 (2f-C), 97.36 (1a-C), 99.50 (1c-C), 99.92 (1e-C), 102.15 (1b-
C), 122.76 (40-C), 138.85 (50-C), 167.85 (1f-C). Anal. Calcd for
3.3. O-(Methyl-5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-
D
-glycero-
tri-O-acetyl-b-
-fucopyranosyl)-(1?3)]-(2-acetamido-6-O-acetyl-2-deoxy-b-
glucopyranosyl)-(1?3)-(2,4,6-tri-O-acetyl-b- -galacto-
pyranosyl)-(1?4)-3,6-di-O-acetyl-2-O-benzoyl-b- -gluco-
a
-
D
-galacto-2-nonulopyranosylonate)-(2?3)-(2,4,6-
D
-galactopyranosyl)-(1?4)-[(2,3,4-tri-O-acetyl-a-
L
D-
D
D
pyranosyl-(1?1)-(2S,3R,4E)-2-azido-3-benzoyl-4-octadecen-
1,3-diol (5)
A solution of sialyl LewisX trichloroacetimidate 326 (450 mg,
216 mol) and (2S,3R,4E)-2-azido-3-(benzoyloxy)-4-octadecen-1-
ol 428 (243 mg, 566
mol) in dry CH2Cl2 (5 mL) was stirred with
molecular sieves AW-300 for 30 min at rt. Then TMSOTf (15.6 L,
86 mol, 0.4 equiv) was added under argon. After 5 h the ini-
l
l
l
l
tially-formed orthoester 6 had rearranged to the desired b-glyco-
side and the solution was neutralized with NEt3, filtrated, and
concentrated. Flash chromatography (2:1 to 3:2 toluene–acetone)
of the residue gave 5 (285 mg, 56%) as a colorless foam (the excess
of 4 can be recovered). [
a
]
ꢁ15.5 (c 1, CHCl3); Rf = 0.56 (2:3 tolu-
C
108H147N5O52ꢀ1/2H2O (2356.36): C, 55.05; H, 6.33; N, 2.97. Found:
D
ene–acetone); 1H NMR (600 MHz, CDCl3): d 0.88 (t, 3H; CH3), 1.18
(d, J5,6 = 6.5 Hz, 3H; 6d-CH3), 1.18–1.33 (m, 22H; 11CH2), 1.68 (m,
1H; 3f-Ha), 1.85–2.20 (m, 56H; 18COCH3, CH@CHCH2), 2.58 (dd,
J3,4 = 4.3, Jgem = 12.4 Hz, 1H; 3f-He), 3.18 (br s, 1H; 2c-H), 3.31–
4.66 [m, 27H; HMQC: 3.45 (5c-H), 3.50 (10-H), 3.63 (6f-H), 3.68
(5a-H), 3.70 (3b-H), 3.75 (5b-H), 3.83 (4a-H), 3.84 (5e-H), 3.85
(COOCH3), 3.87 (4c-H), 3.88 (20-H), 3.93 (10-H), 4.02 (6b-H, 60-b-
H), 4.03 (6c-H), 4.03 (5f-H), 4.08 (9f-H), 4.14 (6a-H), 4.21 (3c-H),
4.22 (6e-H), 4.24 (90f-H), 4.37 (1b-H), 4.38 (90e-H), 4.48 (60a-H),
4.52 (3e-H)], 4.68 (d, J1,2 = 7.8 Hz, 1H; 1a-H), 4.77–5.84 [m, 22H;
HMQC: 4.77 (1e-H), 4.81 (60c-H), 4.88 (4f-H), 4.89 (1c-H), 4.89
(2e-H), 4.94 (2d-H), 4.95 (4e-H), 4.97 (2b-H), 5.00 (5d-H), 5.10
(Nf-H), 5.19 (2a-H), 5.19 (3d-H), 5.31 (4d-H), 5.32 (1d-H), 5.33
(4b-H), 5.36 (3a-H), 5.39 (Nc-H), 5.43 (7f-H), 5.44 (30-H), 5.47 (40-
H), 5.51 (8f-H), 5.83 (50-H)], 7.40–8.00 (m, 10H; 2C6H5); 13C NMR
(151 MHz, CDCl3, excerpt): d 15.79 (6d-C), 37.38 (3f-C), 49.06 (5f-
C), 53.13 (OCH3), 58.3 (2c-C), 60.89 (6c-C), 61.34 (6e-C), 61.49
(6b-C), 61.64 (9f-C), 62.00 (6a-C), 64.07 (5d-C), 64.18 (20-C),
66.57 (7f-C), 67.34 (4e-C), 67.52 (8f-C), 67.94 (3d-C), 68.83 (2d-
C), 68.98 (4b-C), 69.21 (10-C), 69.41 (4f-C), 69.85 (2e-C), 70.92
(5e-C), 71.15 (2b-C), 71.24 (5b-C), 71.35 (3e-C), 71.53 (4d-C),
71.65 (2a-C), 71.99 (6f-C), 72.19 (3a-C), 72.35 (3c-C), 72.97 (5c-
C), 73.11 (5a-C), 74.41 (30-C), 74.23 (4c-C), 75.52 (4a-C), 75.96
(3b-C), 95.27 (1d-C), 96.81 (2f-C), 99.40 (1c-C), 99.88 (1e-C),
100.71 (1b-C), 101.15 (1a-C), 122.82 (40-C), 138.66 (50-C), 167.83
(1f-C). Anal. Calcd for C108H147N5O52ꢀH2O (2365.37): C, 54.84; H,
6.35; N, 2.96. Found: C, 54.73; H, 6.13; N, 2.73.
C, 55.03; H, 6.47; N, 2.55. MALDI-MS (positive mode, THF): m/z
1960.7 [Mꢁazidosphingosine+Na]+, 2373.0 [M+Na]+.
3.5. 12-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)amino]dodecanoic acid (7)
To a suspension of 12-aminododecanoic acid (2.61 g, 12.1
mmol) and NaHCO3 (2.0 g, 24 mmol) in H2O (15 mL) were added
4-chloro-7-nitrobenzofurazane (2.41 g, 12.1 mmol) and MeOH
(100 mL). The mixture was stirred at 50 °C for 1.5 h and then
cooled to rt, neutralized with 10% hydrochloric acid, and evapo-
rated under reduced pressure. The product, which precipitated
after adding H2O, was filtered and absorbed on silica. Flash chro-
matography (1:0 to 9:1 CHCl3–MeOH) afforded 7 (2.93 g, 64%) as
brown crystals. Mp 94 °C; Rf = 0.44 (9:1 CHCl3–MeOH); 1H NMR
(250 MHz, CDCl3): d 1.29–1.87 (m, 18H; 9CH2), 2.35 (t, Jvic = 7.4 Hz,
2H; CH2CO), 3.49 (q, 2H; CH2N), 6.18 (d, J5,6 = 8.7 Hz, 1H; 500-H),
6.38 (br t, 1H; NH), 8.49 (d, 1H; 600-H). Anal. Calcd for
C
18H26N4O5ꢀ1/4H2O (382.93): C, 56.46; H, 6.97; N, 14.63. Found:
C, 56.40; H, 6.72; N, 14.68.
3.6. O-(Methyl-5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-
D
-glycero-
tri-O-acetyl-b-
L-fucopyranosyl)-(1?3)]-(2-acetamido-6-O-acetyl-2-desoxy-b-
-glucopyranosyl)-(1?3)-(2,4,6-tri-O-acetyl-b- -galacto-
pyranosyl)-(1?4)-3,6-di-O-acetyl-2-O-benzoyl-b- -gluco-
a
-D
-galacto-2-nonulopyranosylonate)-(2?3)-(2,4,6-
D
-galactopyranosyl)-(1?4)-[(2,3,4-tri-O-acetyl-a-
D
D
D
pyranosyl-(1?1)-(2S,3R,4E)-3-benzoyl-2-{12-[N-(7-nitrobenz-
2-oxa-1,3-diazol-4-yl)amino]dodecanamido}-4-octadecen-
1,3-diol (8)
3.4. O-(Methyl-5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-
D
-glycero-
tri-O-acetyl-b-
-fucopyranosyl)-(1?3)]-(2-acetamido-6-O-acetyl-2-deoxy-b-
glucopyranosyl)-(1?3)-(2,4,6-tri-O-acetyl-b- -galacto-
pyranosyl)-(1?4)-3,6-di-O-acetyl-2-O-benzoyl-b- -gluco-
a
-
D
-galacto-2-nonulopyranosylonate)-(2?3)-(2,4,6-
D
-galactopyranosyl)-(1?4)-[(2,3,4-tri-O-acetyl-a-
L
D
-
A solution of 5 (82 mg, 35 lmol) in 4:1 pyridine–H2O (25 mL)
D
was saturated with hydrogen sulfide at 0 °C for 30 min and then
stirred at rt for 3 d, concentrated, and coevaporated with toluene
(3ꢂ). The residue was diluted in dry CH2Cl2 (10 mL), and 7
D
pyranose- 1,2-[(2S,3R,4E)-2-azido-3-(benzoyloxy)-4-octadec-
1-yl-orthobenzoate] (6)
(26 mg, 69 lmol) and EDCI (33 mg, 174 lmol) were added. After
16 h the mixture was diluted with H2O (10 mL) and extracted with
CH2Cl2 (3 ꢂ 30 mL). The combined organic layers were dried
(Na2SO4), filtered, and concentrated. Flash chromatography (3:2
If the reaction described above was neutralized after 1 h, the
orthoester 6 was isolated as the main product. [
ꢁ19.1 (c 1,
a]
D